New chief Pamela Rendi-Wagner says European Centre for Disease Prevention and Control (ECDC) should do more to combat ...
The Belgian medicines agency, an important stakeholder in the revision of the European pharmaceutical legislation, is ...
LONDON, UK I4, 2024 I Duke Street Bio Ltd, a precision medicine biotech developing next generation small molecule cancer therapies, is pleased to ...
Committee for Human Medicinal Products (CHMP) recommended approval of five novel medicines at its September meeting ...
Greater collaboration between industry, government, policymakers and the NHS will be critical for treatment options in the UK ...
Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...
EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...
European Commission Approves LEO Pharma’s Anzupgo® (delgocitinib) Cream for Adults with Moderate to Severe Chronic Hand ...
EMA’s human medicines committee recommends approval of Henlius’ Hansizhuang to treat extensive-stage small cell lung cancer: Shanghai, China Monday, September 23, 2024, 16:00 ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Pharmaceutical Technology on MSN3d
Ipsen’s Iqirvo wins European approval for primary biliary cholangitisThe European Commission (EC) has conditionally approved Ipsen ’s Iqirvo (elafibranor) for the treatment of primary biliary ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback